Search results
Smart Money Is Betting Big In BMY Options - Bristol-Myers Squibb (NYSE:BMY)
Benzinga· 4 days agoLoading... Loading... Whales with a lot of money to spend have taken a noticeably bearish stance on Bristol-Myers Squibb . Looking at options history for Bristol-Myers Squibb BMY we detected ...
Bristol Myers Squibb's Augtyro Gets FDA Accelerated Approval
Morningstar· 5 days agoBy Denny Jacob Bristol Myers Squibb disclosed that the U.S. Food and Drug Administration granted accelerated approval of Augtyro. The biopharmaceutical product developer said the approval is based on results from a Phase 1/2 study which
Gateway - Quartz
Quartz· 22 hours agoEvery pharmaceutical company is constantly searching for its next blockbuster — the billion-dollar drug that dominates a market, brings in hordes of customers, and deposits hefty profits in ...
3 High-Yield S&P 500 Dividend Stocks Down More Than 25% to Buy Now and Hold for at Least a Decade
Motley Fool via Yahoo Finance· 3 days agoThe S&P 500 is up an incredible 25% over the past 12 months, but not every stock in the benchmark...
3 High-Yield S&P 500 Dividend Stocks Down More Than 25% to Buy Now and Hold for at Least a Decade |...
The Motley Fool· 3 days agoThe S&P 500 is up an incredible 25% over the past 12 months, but not every stock in the benchmark...
M&A Is Back. 4 Stocks That Could Be Targets.
Barrons.com· 2 hours agoMergers are back—and that means opportunity for small-cap investors. The return of M&A has been helped along by a number of factors, including a...
Bristol Myers (BMY) Gets FDA Nod for Label Expansion of Augtyro
Zacks via Yahoo Finance· 5 days agoThe FDA approves Bristol Myers' (BMY) cancer drug Augtyro for the treatment of adult and pediatric...
EU regulator mandates label updates on CAR-T cancer therapies
Reuters via AOL· 5 days agoThe European Medicines Agency's (EMA) mandate, which echoes the one issued by the U.S. health...
Gateway - Quartz
Quartz· 1 day agoQuartz is a guide to the new global economy for people who are excited by change. We cover business, finance, economics, technology, lifestyle, and leadership.
EU regulator mandates label updates on CAR-T cancer therapies
Reuters· 5 days agoThe European health regulator said on Friday product information for a class of cancer therapies...
